• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Circadian variations of interleukin-2 receptors, serum thymidine kinase and beta-2-microglobulin in patients with non-Hodgkin's lymphoma and normal controls.

作者信息

Micke O, Schäfer U, Wörmann B, Hiddemann W, Willich N

机构信息

Klinik und Poliklinik für Strahlentherapie-Radioonkologie, Westfälische Wilhelms-Universität, Münster, Germany.

出版信息

Anticancer Res. 1997 Jul-Aug;17(4B):3007-10.

PMID:9329587
Abstract

In this study we investigated whether circadian rhythms of interleukin-2 receptors (sIL-2R), serum thymidine kinase (sTK) and beta-2-microglobulin (beta 2M) are apparent, which may influence tumor marker detection. Blood was drawn every two hours over 24 hours from 6 patients with NHL, 3 healthy donors and three patients with non-hematologic disorders. The serum levels of the three markers were measured. The three normal volunteers showed circadian variations of sIL-2R, sTK and beta 2M best described by a sinusoidal curve. This rhythm could also be demonstrated in three of the six patients with NHL for all three markers. In three patients the circadian rhythm of one marker was disturbed. The three NHL-patients with consistent circadian rhythms in all three markers achieved a complete remission, whereas the patients with disturbed rhythm progressed under therapy. We showed that circadian variations of sIL-2R, sTK and beta 2M follow a sinusoidal circadian rhythm in normals and patients with NHL. Disturbance of this rhythm may be related to a worse prognosis.

摘要

相似文献

1
Circadian variations of interleukin-2 receptors, serum thymidine kinase and beta-2-microglobulin in patients with non-Hodgkin's lymphoma and normal controls.
Anticancer Res. 1997 Jul-Aug;17(4B):3007-10.
2
[Clinical significance of serum soluble interleukin-2 receptor level in patients with non-Hodgkin's lymphoma].[血清可溶性白细胞介素-2受体水平在非霍奇金淋巴瘤患者中的临床意义]
Rinsho Ketsueki. 1999 Aug;40(8):639-45.
3
[Detection of soluble interleukin-2 receptor in the serum of patients with non-Hodgkin's lymphoma].[非霍奇金淋巴瘤患者血清中可溶性白细胞介素-2受体的检测]
Med Clin (Barc). 1998 Jul 11;111(5):161-7.
4
[The serum levels of soluble interleukin-2 receptor in patients with malignant lymphocytic proliferative disorders].[恶性淋巴细胞增殖性疾病患者血清可溶性白细胞介素-2受体水平]
Zhonghua Xue Ye Xue Za Zhi. 1998 Feb;19(2):82-4.
5
Serum soluble interleukin-2 receptor, beta2-microglobulin, lactate dehydrogenase and erythrocyte sedimentation rate in children with Hodgkin's lymphoma.霍奇金淋巴瘤患儿的血清可溶性白细胞介素-2受体、β2-微球蛋白、乳酸脱氢酶及红细胞沉降率
Scand J Immunol. 2009 Nov;70(5):490-500. doi: 10.1111/j.1365-3083.2009.02313.x.
6
Serum thymidine kinase and soluble interleukin-2 receptor predict recurrence of malignant lymphoma.血清胸苷激酶和可溶性白细胞介素-2受体可预测恶性淋巴瘤的复发。
Ann Hematol. 2002 Mar;81(3):140-6. doi: 10.1007/s00277-001-0421-8. Epub 2002 Feb 9.
7
Serum tumor markers in non-Hodgkin's lymphomas and chronic lymphocytic leukemia.非霍奇金淋巴瘤和慢性淋巴细胞白血病中的血清肿瘤标志物
Int J Biol Markers. 1993 Jan-Mar;8(1):14-20. doi: 10.1177/172460089300800103.
8
Serum CA 125 is of clinical value in the staging and follow-up of patients with non-Hodgkin's lymphoma: correlation with tumor parameters and disease activity.血清CA 125在非霍奇金淋巴瘤患者的分期及随访中具有临床价值:与肿瘤参数及疾病活动的相关性
Cancer. 1998 Feb 1;82(3):576-82.
9
Clinical significance of serum neuron-specific enolase in patients with adult T-cell leukemia.血清神经元特异性烯醇化酶在成人T细胞白血病患者中的临床意义
Am J Hematol. 2002 Oct;71(2):80-4. doi: 10.1002/ajh.10190.
10
Detection of soluble IL-2 receptor in the serum and bone marrow of patients with minimal residual hematological malignancies: induction under therapy with IL-2.微小残留血液系统恶性肿瘤患者血清和骨髓中可溶性白细胞介素-2受体的检测:白细胞介素-2治疗诱导情况
Arch Immunol Ther Exp (Warsz). 1997;45(5-6):443-8.

引用本文的文献

1
Transcription factor CCAAT/enhancer-binding protein alpha and critical circadian clock downstream target gene PER2 are highly deregulated in diffuse large B-cell lymphoma.转录因子 CCAAT/增强子结合蛋白α和关键生物钟下游靶基因 PER2 在弥漫性大 B 细胞淋巴瘤中高度失调。
Leuk Lymphoma. 2012 Aug;53(8):1577-85. doi: 10.3109/10428194.2012.658792. Epub 2012 Feb 21.
2
Clock-cancer connection in non-Hodgkin's lymphoma.非霍奇金淋巴瘤中的生物钟与癌症关联
Med Hypotheses. 2008;70(4):788-92. doi: 10.1016/j.mehy.2007.07.040. Epub 2007 Nov 1.
3
Ala394Thr polymorphism in the clock gene NPAS2: a circadian modifier for the risk of non-Hodgkin's lymphoma.
生物钟基因NPAS2中的Ala394Thr多态性:非霍奇金淋巴瘤风险的昼夜节律调节因子。
Int J Cancer. 2007 Jan 15;120(2):432-5. doi: 10.1002/ijc.22321.